C07D 209/68
With oxygen and nitrogen atoms in positions 1 and 3
Official title: with oxygen and nitrogen atoms in positions 1 and 3
C07D209/68 (With oxygen and nitrogen atoms in positions 1 and 3) appears on 10 US grants and 3 published applications in this corpus.
Search patents in C07D- Granted patents
- 10
- Published applications
- 3
- Assignees
- 5
- Inventors
- 24
- Latest grant
- 21 Dec 2010
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Organoelectroluminescent compound and organoelectroluminescent device employing the same21 Dec 2010US 7,854,999 B2Samsung Mobile Display Co., Ltd.
- Carbazole based charge transport compounds28 Dec 2004US 6,835,513 B2Samsung Electronic Co., Ltd.
- Thiophene-containing butonic acid derivatives as matrix metalloprotease inhibitors23 Mar 1999US 5,886,024 ABayer Aktiengesellschaft
- Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors23 Mar 1999US 5,886,043 ABayer Aktiengesellschaft
- Substituted cycloalkanecarboxylic acid derivatives as matrix metalloprotease inhibitors23 Feb 1999US 5,874,473 ABayer Aktiengesellschaft
- Photoredox Catalysts And Methods Of Using Such Catalysts23 Mar 2023US 2023/0090784 A1Colorado State University Research Foundation
- Organoelectroluminescent compound and organoelectroluminescent device employing the same1 May 2008US 2008/0100207 A1Samsung Mobile Display Co., Ltd.
- Carbazole based charge transport compounds6 Nov 2003US 2003/0207188 A1Samsung Electronic Co., Ltd.
Most cited
By later US patents
- Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors28US 5,789,434 ABayer Aktiengesellschaft · 1998
- Carbazole based charge transport compounds27US 6,835,513 B2Samsung Electronic Co., Ltd. · 2004
- Thiophenebutanoic acid derivatives as matrix metalloprotease inhibitors7US 5,854,277 ABayer Aktiengesellschaft · 1998
- Organoelectroluminescent compound and organoelectroluminescent device employing the same5US 7,854,999 B2Samsung Mobile Display Co., Ltd. · 2010
- Substituted 4-biarylbutyric acid derivatives as matrix metalloprotease inhibitors4US 5,859,047 ABayer Aktiengesellschaft · 1999